References
- Bosma G. C., Custer R. P., Bosma M. J. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301: 527
- Bosma G. C., Davisson M. T., Ruetsh N. R., Sweet H. O., Schultz L. D., Bosma M. J. The mouse mutation severe combined immune deficiency (SCID) is on chromosome 16. Immunogenetics 1989; 29: 54
- Schuler W., Weiler I. J., Schuler A., Phillips R. A., Rosenberg N., Mark T. W., Kearney J. F., Perry R. P., Bosma M. J. Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell 1986; 46: 963
- Malynn B. A., Blackwell T. K., Fulop G. M., Rathbun G. A., Furley A. J.W., Ferrier P., Heinke L. B., Phillips R. A., Yancoponlos G., Alt F. W. The SCID defect effects the final step of the immunoglobulin VDJ recombinase mechanism. Cell 1988; 54: 453
- McCune J. M., Namikawa R., Kaneshima H., Shultz L. D., Lieberman M., Weissman I. L. The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 1988; 241: 1632
- Mosir D., Gulizia R. T., Baird S. M., Wilson D. B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335: 256
- Namikawa R., Kaneshima H., Lieberman M., Weissman I. L., McCune J. M. Growth of human tumors in immune-deficient SCID mice and nude mice. Curr. Top. Microbiol. Immunol. 1988
- Phillips R. A., Jewett M. A. S., Gallie B. L. Infection of the SCID-hu mouse by HIV-1. Science 1989; 152: 259
- Ghetie M. A., Richardson J., Tucker T., Jones D., Uhr J. W., Vitetta E. S. Disseminated or localized growth of a human B-cell tumor (Daudi) in SCID mice. Int. J. Cancer 1990; 45: 481
- Schmidt-Wolf I. G. H., Negrin R. S., Kiem H. P., Blume K. G., Weissman I. L. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potential anti-tumor cell activity. J. Exp. Med. 1991; 174: 139
- Kamel-Reid S., Letarte M., Sirard C., Doedenns M., Grunberger T., Fulop G., Freedman M. H., Phillips R. A., Dick J. E. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science 1989; 246: 1597
- Cesano A., O'Connor R., Lange B., Finan J., Rovera G., Santoli D. Homing and progression patterns of childhood acute lymphoblastic leukemia in severe combined immuno deficiency mice. Blood 1991; 77: 2463
- Lord C. D., Clutterbuck R., Titley J., Ormerod M., Gordon-Smith T., Millar J., Powles R. Growth of primary human leukemia in severe combined immunodeficient mice. Exp. Hematol. 1991; 19: 991
- Chang H., Jamal N., Wang X. H., Minden M., Messner H. A. Constitutive production of the interleukins IL-5 and IL-6 by the lymphoma cell line OCI-LY17 derived from a patient with malignant lymphoma and hypereosinophilia. Leukemia and Lymphoma. 1992, In press
- Chang H., Yee C., Wang X. H., Addy L., Meharchand J., Minden M., Messner H. A. A human lymphoma cell line with multiple immunoglobulin rearrangements. J. Clin. Invest. 1992; 89: 1014
- Tweeddale M. E., Lim B., Jamal N., Robinson J., Zalcberg J., Lockwood G., Minden M., Messner H. A. The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor. Blood 1987; 69: 1307
- Waller E. K., Kamel O. W., Cleary M. L., Majumdar A. S., Schick M. R., Lieberman M., Weissman I. L. Growth of primary T-cell Non-Hodgkin's lymphomata in SCID-hu mice: Requirement for a human lymphoid microenvironment. Blood 1991; 78: 2650
- Murphy J. R. Diphtheria-related peptide hormone gene fusions: A molecular genetics approach to chimeric toxin development. Immunotoxins, A. E. Frankel. Kluwer Academic Publishers. 1988; PI23
- Siegall C. B., Kreitman R. J., FitzGerald D. J., Pastan I. Antitumor effects of interleukin 6-Pseudomonas exotoxin chimeric molecules against the human hematocellular carcinoma, PLC/PRF/5 in mice. Cancer Research 1988; 51: 2831